BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25581762)

  • 1. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
    Schuetz P; Balk R; Briel M; Kutz A; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Lacey MJ; Ohsfeldt RL; Scheibling CM; Schneider JE
    Clin Chem Lab Med; 2015 Mar; 53(4):583-92. PubMed ID: 25581762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective.
    Stojanovic I; Schneider JE; Wei L; Hong Z; Keane C; Schuetz P
    Clin Chem Lab Med; 2017 Mar; 55(4):561-570. PubMed ID: 27658150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin-guided antibiotic therapy: a potentially effective and efficient strategy.
    Plebani M; Fabbri LM
    Clin Chem Lab Med; 2015 Mar; 53(4):519-20. PubMed ID: 25741739
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
    Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
    PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults.
    Michaelidis CI; Zimmerman RK; Nowalk MP; Fine MJ; Smith KJ
    J Gen Intern Med; 2014 Apr; 29(4):579-86. PubMed ID: 24234394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
    Harrison M; Collins CD
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.
    Heyland DK; Johnson AP; Reynolds SC; Muscedere J
    Crit Care Med; 2011 Jul; 39(7):1792-9. PubMed ID: 21358400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How efficient is procalcitonin-guided antibiotic use in acute respiratory tract infections in primary care?
    Brusius AC; Zavascki AP; Fuchs SC
    Arch Intern Med; 2009 Jul; 169(13):1244. PubMed ID: 19597077
    [No Abstract]   [Full Text] [Related]  

  • 17. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
    Schuetz P; Chiappa V; Briel M; Greenwald JL
    Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
    Martinez FJ; Curtis JL
    Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of procalcitonin in respiratory tract infections across clinical settings.
    Kutz A; Briel M; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Schuetz P
    Crit Care; 2015 Mar; 19(1):74. PubMed ID: 25887979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin-based guidelines and lower respiratory tract infections.
    Cals JW; Metlay JP
    JAMA; 2010 Feb; 303(5):418; author reply 419-20. PubMed ID: 20124534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.